Quick Facts

• May assist in the management of: Minor cuts, scrapes, and abrasions
• May be used for: The prevention and treatment of superficial skin infections
• Indicated for: Localized non-bullous impetigo in individuals aged two years and older
• Potential use in: Mild to moderate acne vulgaris

---

Crystaderm is utilized as a topical antiseptic for the care of minor skin trauma and associated infections. The product is approved for the prevention and treatment of infection in minor cuts, wounds, and scrapes. It may assist in the management of superficial skin infections caused by microorganisms that are sensitive to the active ingredient.

Crystaderm is indicated for the management of localized non-bullous impetigo in patients who are two years of age and older. It is also being studied for its potential role in the management of mild to moderate acne vulgaris. The active compound is classified as an antiseptic agent that may offer a benefit in these therapeutic domains.

The product is formally registered for use as a first aid antiseptic to help treat and prevent infection in minor cuts, wounds, and abrasions. For all uses, treatment regimens should be guided by a healthcare professional.

Eligibility for Crystaderm Cream

Official regulatory documents define specific populations who are permitted to use or are strictly prohibited from using Crystaderm (1% w/w Hydrogen Peroxide cream).

Category	Eligibility Status
Populations for whom use is allowed	Individuals aged two years and older for the labeled topical uses.
Populations for whom use is contraindicated	Patients with a known hypersensitivity to Hydrogen Peroxide or any of the cream’s excipients, and in the presence of strong oxidizing agents.
Age-related eligibility rules	Approved for patients aged two years and older. Use is not established or not recommended for children under two years of age.
Pregnancy and lactation eligibility	Use during pregnancy is considered generally acceptable with caution. During lactation, use is generally allowed, but application to the breast area must be avoided.

Regulatory criteria establish that the cream is contraindicated based on ingredient sensitivity, representing an absolute exclusion. The minimum age of two years is the threshold for established use for the labeled indications. For patients with systemic conditions, such as renal or hepatic impairment, no specific restrictions are documented due to the product’s topical administration.

Interactions with other medicines and products

Crystaderm (Hydrogen Peroxide 1% w/w topical cream) is classified as a locally-acting antiseptic. Due to the product's exclusive topical application and negligible systemic absorption, its officially documented interaction profile is focused entirely on the site of application, according to regulatory information.

Documented Topical Interactions

Interaction Type	Interacting Substance/Product	Regulatory Restriction
Local Chemical Incompatibility	Potassium Permanganate or other strong reducing/oxidizing agents.	Avoid co-administration due to the risk of local chemical inactivation of the active ingredient.
Administration Interference	Other topical preparations, creams, or ointments.	Must not be applied simultaneously to the same area to prevent potential dilution or physical interference with the antiseptic action.

Systemic Interaction Profile

Regulatory documents do not list any clinically significant systemic interactions concerning pharmacokinetic or pharmacodynamic effects with orally administered medicines. This absence of documented systemic interaction is consistent with the product's defined usage, as the active ingredient is rapidly degraded locally and lacks the systemic exposure required to interfere with metabolic pathways (such as CYP enzymes) or drug transporters. Therefore, no restrictions are imposed regarding concomitant use with orally ingested medicines, food, alcohol, or supplements.

How Crystaderm Works: Mechanism of Action

Crystaderm (Hydrogen Peroxide 1% w/w) functions through a direct, chemical mechanism confined to the site of application.

Initiating Radical-Mediated Cell Destruction

The primary action is the generation of oxidative stress. Upon application, the active molecule rapidly decomposes, releasing hydroxyl free radicals (cdot OH). These unstable, highly reactive molecules immediately attack the microorganisms' essential structures, including the lipids of the cell membrane, the proteins required for metabolism, and the nucleic acids (DNA/RNA). This chemical disruption of fundamental cell components leads directly to microbial cell death (lysis).

Localized Action and Self-Limiting Cascade

The physiological consequence of this destruction is a decrease in the concentration of viable microorganisms at the application site. This chemical effect is strictly limited to the site of application because the drug is rapidly neutralized by the enzyme catalase, which is abundant in human tissue and blood. The quick breakdown of the active compound into water and oxygen prevents it from penetrating deeper tissues, confining its chemical action to the surface.

Crystaderm is a 1% w/w hydrogen peroxide cream used for external, topical application to the skin. The use of this medicine follows a standardized application protocol, with defined requirements for preparation, frequency, and duration.

Administration Guidelines

Administration Scope	Requirement (1% Hydrogen Peroxide Cream)
Route of Administration	Topical (External use only)
Dosing Schedule	Apply a thin layer of the cream, sufficient only to cover the affected area.
Frequency	Apply two to three times daily (2-3 times/day) to the treatment site.
Age Group Rule	Approved for use in adults, the elderly, and children aged 2 years and older.
Course Duration	Short-term use; the maximum treatment period should not exceed three weeks.

Procedural Instructions

Standard procedure involves cleansing the skin before the application of the cream. The common method is to gently cleanse the affected area with water and a mild soap prior to application. Following this, the thin layer of cream is applied to the site. The cream forms a dry film after application, which can be easily washed off with water.

Special Note: The cream is not used concurrently with strong oxidizing agents, such as iodine or permanganates. The administration protocol is designed for localized, non-systemic use, and the regimen is maintained consistently throughout the short treatment course.

Research evidence / Overview of Studies for Crystaderm

Evidence for Use in Localized Non-Bullous Impetigo

Research has primarily focused on evaluating Hydrogen Peroxide 1% cream through Randomized Controlled Trials (RCTs) and multicenter comparative studies. These investigations were applied in research contexts exploring the effect on superficial bacterial skin infections, specifically localized non-bullous impetigo. The trials included both pediatric and adult patients (aged two years and older) with this condition. Researchers monitored outcomes related to symptom intensity or variability, such as measurements of clinical cure or improvement, changes in composite severity scores, and bacteriological measurements of the microbes at the site of infection.

Studies tracked how symptoms evolved in the observed populations during the short-term treatment and follow-up periods. Comparative trials described measurements of clinical endpoints and bacteriological changes that were noted in cohorts receiving established first-line topical antibiotic treatments.

---

Evidence for Use as a First-Aid Antiseptic

The foundation for this first-aid application relies primarily on in vitro pharmacology studies and the regulatory review of the active ingredient's established antiseptic properties. Researchers examined the cream's active ingredient in the laboratory to measure its bactericidal activity—its ability to destroy a wide range of common bacteria and fungi. Studies also explored the stabilized cream formulation to assess its antimicrobial properties over time.

Regulatory bodies and scientific reviews describe the compound’s classification as a broad-spectrum antiseptic. This evidence describes the scientific basis for the product being studied in superficial injuries. These findings describe patterns observed in the studies conducted in a controlled environment.

---

Research Findings for Mild to Moderate Acne Vulgaris

Research has explored the use of the cream for mild to moderate acne vulgaris. The evidence is derived from Randomized Clinical Trials (RCTs) and investigator-masked comparative trials. These studies was evaluated in patient cohorts, typically young adults, with mild to moderate forms of the condition. The studies monitored outcomes such as the total number of acne lesions (both inflammatory and non-inflammatory) and changes in standardized clinical grading scales.

---

What Research Gaps and Uncertainty Remain

There are several areas where the research landscape remains uncertain or where comparative evidence is lacking. For the common first-aid antiseptic use, the evidence relies heavily on strong laboratory (in vitro) data, meaning specific clinical trials comparing the cream against placebo or simple cleaning for minor wounds are lacking.

Furthermore, follow-up durations were limited across all indications, including both impetigo and acne studies. This limitation means long-term effects are not fully established, and the evidence applies only to the populations studied, leaving gaps regarding use in special patient subgroups.

Key Studies & References

1. Hydrogen Peroxide 1% Cream versus Fusidic Acid for Impetigo: A Randomized Controlled Trial
2. Clinical Guideline for the Management of Impetigo (referencing topical hydrogen peroxide)
3. Randomized Clinical Trial of Hydrogen Peroxide 1% Cream for Mild to Moderate Acne Vulgaris

Common questions about Crystaderm (FAQ)

---

Q: Is there a reason why Crystaderm is sometimes preferred over iodine solutions?

Official information describes that the cream must not be used at the same time as strong oxidizing agents, such as iodine or permanganates, because of the potential for local chemical inactivation. The product is also classified as a lipid-stabilized cream formulation, which represents a different chemical base compared to typical aqueous iodine solutions.

---

Q: Is Crystaderm considered a prescription-strength drug, or is it always over-the-counter?

Crystaderm is consistently described in regulatory documents as an over-the-counter (OTC) medicine. In most regulatory frameworks, it is not classified or scheduled for use as a prescription-only medicine.

---

Q: How long can a person expect to use Crystaderm before they should see improvement?

The official administration guidelines set a maximum treatment period of three weeks. If symptoms are still present after three weeks, official patient information indicates consulting a healthcare professional is appropriate.

---

Q: Does Crystaderm interact with supplements or herbal products?

Regulatory documents state that due to the cream being applied locally to the skin, very little of the active ingredient enters the body. For this reason, no restrictions are imposed regarding concomitant use with orally ingested supplements, herbal products, food, or alcohol.

---

Q: Are there specific official warnings about using Crystaderm near the eyes or mouth?

Official warnings strongly advise that contact with the eyes must be avoided. Official guidance states that if the cream accidentally gets into the eyes, washing the area out immediately with cold water is the recommended action. The product is strictly for external use on the skin, and official guidance confirms it must not be placed in the mouth.

---

Q: What general expectations about healing time are associated with the conditions Crystaderm treats?

The maximum treatment period for the cream is defined as three weeks in regulatory documents. This maximum course duration reflects the established timeline for short-term use in clinical guidelines for the approved superficial skin conditions.

---

Q: Can Crystaderm be used for acne or pimples?

Official regulatory documents and patient information confirm that the cream is used to treat minor skin infections, including mild to moderate acne as well as impetigo.

---

Q: Why might a doctor prescribe or recommend Crystaderm instead of a common antibiotic ointment?

Official documentation classifies the product as an antibiotic-free antiseptic. A distinct feature noted in product documentation is that its use is not associated with the development of bacterial resistance, unlike some topical antibiotic treatments.

---

Q: Is it possible to be allergic to the non-active ingredients in Crystaderm?

Yes, official safety constraints state that the medicine must not be used if there is a known allergy or hypersensitivity to the active substance or any of the excipients (non-active ingredients) in the cream. Documented effects include allergic dermatitis caused by excipients such as Salicylic acid and Propylene glycol.

---

Q: What happens if Crystaderm is accidentally swallowed in a very small amount?

Patient guidelines for external-use creams indicate that if the product is swallowed accidentally, seeking immediate medical assistance, such as informing a doctor or contacting emergency services, is the general guidance.

---

Q: Does the use of Crystaderm change the natural color of the skin?

Official product information describes that the cream does not stain skin or hands. No side effect of permanent skin discoloration is listed in regulatory documentation.

---

Q: Is Crystaderm known to cause a reaction with common fabrics or jewelry?

Official product information indicates that the cream does not stain fabric. There are no specific documented warnings or precautions concerning incompatibility with jewelry.

---

Q: What is the recommended process if a person misses an application of Crystaderm?

Official patient guidance states that if a person forgets to apply a dose, they should do so as soon as they remember. After this, the person should then continue the application schedule as usual.

---

Q: Can people with sensitive skin use Crystaderm?

Official labeling notes that the cream contains excipients, such as Propylene glycol, which may cause skin irritation. While the cream is generally well tolerated, a mild sensation of burning or stinging is frequently reported in official documents.

Storage and Disposal of Crystaderm

Official regulatory documentation outlines specific requirements for storing and handling Crystaderm (hydrogen peroxide cream) to maintain product stability and ensure safety.

---

Official Storage Conditions

Category	Regulatory Requirement
Temperature	Must be stored below 25 degrees Celsius
Protection	Store in a dry place
Child Safety	Keep this medicine out of the reach of children
Stability	Do not use or keep the medicine after its expiry date

Disposal Requirements

Unused or expired Crystaderm must be disposed of according to national guidelines. General regulatory advice specifies that medicines should not be discarded via wastewater or household garbage. Users are instructed to consult a pharmacist for guidance on proper disposal, such as using an authorized medicine take-back program.